1. Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders.
- Author
-
Glenthøj, Andreas, Jakobsen, Lasse H., Bjørn, Mads Emil, Poulsen, Christian B., Sengeløv, Henrik, Severinsen, Marianne T., Qvist, Kristian, Overgaard, Ulrik M., Ahmad, Syed A., Rewes, Annika, Mølle, Ingolf, Strandholdt, Casper N., Kodahl, Annette R., Ryg, Jesper, Brieghel, Christian, Johansen, Isik S., Kannik, Karina, Jensen-Fangel, Søren, Wiese, Lothar, and Kirk, Ole
- Subjects
COVID-19 ,ACQUISITION of data methodology ,CONFIDENCE intervals ,SELF-evaluation ,COVID-19 vaccines ,GERIATRIC assessment ,FISHER exact test ,MONOCLONAL antibodies ,SEVERITY of illness index ,RISK assessment ,BLOOD diseases ,PUBLIC hospitals ,MEDICAL records ,DESCRIPTIVE statistics ,KAPLAN-Meier estimator ,LOGISTIC regression analysis ,DATA analysis software ,COMORBIDITY ,LONGITUDINAL method ,DISEASE complications ,EVALUATION - Abstract
The article discusses severity and survival among severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Danish patients with haematological disorders before September 2020. Topics covered include the profile of patients, the highest mortality rate during the first few weeks, among older patients and those with comorbidity, and those with haematological diseases. Also noted is the importance for the latter group of monoclonal antibodies against SARS-CoV-2 spike protein.
- Published
- 2022
- Full Text
- View/download PDF